About Daniel Yadegar
Daniel Yadegar is a director at Rinascera Therapeutics.
Form D filings also name Daniel Yadegar as a director at DermBiont.
Daniel Yadegar first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Yadegar in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Yadegar works with at each company, as listed on that company's latest Form D.
Rinascera Therapeutics, Inc. · Form D, Oct 8, 2025
NE
Nichola Eliovits
Chief Executive Officer and director
MD
Max Dawson
Executive officer
KB
Karl Beutner
Executive officer and director
DermBiont, Inc. · Form D/A, Nov 13, 2024
SB
Steven Basta
Director
KB
Karl Beutner
Chief Executive Officer and director
NE
Nichola Eliovits
Executive officer and director
MD
Max Dawson
Executive officer
WR
Wilder Ramsey
Director